Cocrystal Pharma (COCP) Capital Expenditures Growth (5y) (2015 - 2024)
Cocrystal Pharma (COCP) Capital Expenditures Growth (5y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -20.38% |
| Dec 31, 2023 | 31.51% |
| Mar 31, 2023 | 55.18% |
| Dec 31, 2021 | 31.95% |
| Sep 30, 2021 | -21.00% |
| Jun 30, 2021 | -3.58% |
| Mar 31, 2021 | 6.79% |
| Dec 31, 2020 | -61.74% |
| Sep 30, 2018 | -27.67% |
| Mar 31, 2018 | -34.18% |
| Jun 30, 2017 | -27.71% |
| Mar 31, 2017 | -32.89% |
| Dec 31, 2016 | -65.64% |
| Sep 30, 2016 | -38.54% |
| Jun 30, 2016 | 25.87% |
| Mar 31, 2016 | -6.29% |
| Dec 31, 2015 | 88.17% |